crico-tracheal resection

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    晚期甲状腺癌(TC)的气道受累构成阴性预后指标,除了是一个关键的临床问题,因为它代表了局部晚期疾病中最常见的死亡原因之一。人们普遍认为,对于适当的喉-气管入侵模式,在这种临床情况下,(环状)气管切除和初次吻合[(C)TRA]是首选的手术技术。然而,(C)TRA的长期结果在文献中很少见,由于这类案件的罕见。数据的相对匮乏促使对可用的相关系列进行仔细审查,以便从肿瘤学和功能角度对这种手术技术进行严格评估。根据PubMed上的系统评价和荟萃分析声明的首选报告项目进行了系统评价,Scopus,和WebofScience数据库。在1985年1月至2021年8月之间发表的英语外科手术系列,包括通过(C)TRA治疗TC浸润气道的≥5例患者的报告数据。肿瘤学结果,死亡率,并发症,评估气管切开依赖率。对每个终点进行了汇总比例估计。纳入了37项研究,共656名患者。围手术期总死亡率为2.0%。27.0%的患者报告了手术并发症,以单发或双侧喉返神经麻痹最为常见。4.0%的患者需要永久性气管切开术。不同系列的肿瘤结局各不相同,5年和10年总生存率从61%到100%和42.1%到78.1%不等。分别。5年和10年疾病特异性生存率从75.8%到90%和54.5%到62.9%不等。分别。因此,(C)TRA治疗的局部晚期TC伴气道浸润可提供可接受的肿瘤学结果,且永久性气管切开率低.报告的并发症发生率,然而,表明需要明智的患者选择,细致的手术技术,和精心的术后管理。
    Airway involvement by advanced thyroid carcinoma (TC) constitutes a negative prognosticator, besides being a critical clinical issue since it represents one of the most frequent causes of death in locally advanced disease. It is generally agreed that, for appropriate laryngo-tracheal patterns of invasion, (crico-)tracheal resection and primary anastomosis [(C)TRA] is the preferred surgical technique in this clinical scenario. However, the results of long-term outcomes of (C)TRA are scarce in the literature, due to the rarity of such cases. The relative paucity of data prompts careful review of the available relevant series in order to critically evaluate this surgical technique from the oncologic and functional points of view. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement on the PubMed, Scopus, and Web of Science databases. English-language surgical series published between January 1985 and August 2021, reporting data on ≥5 patients treated for TC infiltrating the airway by (C)TRA were included. Oncologic outcomes, mortality, complications, and tracheotomy-dependency rates were assessed. Pooled proportion estimates were elaborated for each end-point. Thirty-seven studies were included, encompassing a total of 656 patients. Pooled risk of perioperative mortality was 2.0%. Surgical complications were reported in 27.0% of patients, with uni- or bilateral recurrent laryngeal nerve palsy being the most common. Permanent tracheotomy was required in 4.0% of patients. Oncologic outcomes varied among different series with 5- and 10-year overall survival rates ranging from 61% to 100% and 42.1% to 78.1%, respectively. Five- and 10-year disease specific survival rates ranged from 75.8% to 90% and 54.5% to 62.9%, respectively. Therefore, locally advanced TC with airway invasion treated with (C)TRA provides acceptable oncologic outcomes associated with a low permanent tracheotomy rate. The reported incidence of complications, however, indicates the need for judicious patient selection, meticulous surgical technique, and careful postoperative management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    OBJECTIVE: We aimed to obtain information on the number of Nordic centers performing tracheal resections, crico-tracheal resections, and laryngo-tracheal reconstructions, as well as the patient volume and the standard regimens associated with these procedures.
    METHODS: Consultants at all Departments of Otorhinolaryngology-Head and Neck Surgery (ORL-HNS, n = 22) and Thoracic Surgery (n = 21) in the five Nordic countries were invited (April 2018-January 2019) to participate in an online survey.
    RESULTS: All 43 departments responded to the survey. Twenty departments declared to perform one or more of the three types of tracheal resections. At five hospitals, departments of ORL-HNS and Thoracic Surgery perform these operations in collaboration. Hence, one or more of the tracheal operations in question are carried out at 15 centers. The median annual number of tracheal operations per center is five (range 1-20). Great variations were found regarding contraindications (relative and absolute) for surgery, the use of guardian sterno-mental sutures (all patients, 33%; selected cases, 40% of centers), prophylactic antibiotic therapy (cefuroxime +/- metronidazole, penicillin +/- metronidazole, clindamycin, imipenem, or none), post-operative follow-up time (range: children: 3-120 months; adults: 0-60 months), and the performance of post-operative bronchoscopy.
    CONCLUSIONS: Fifteen centers each perform a low number of annual operations with significant variations in the selection of patients and the clinical setup, which raises the question if a higher degree of collaboration and centralization would be warranted. We encourage Nordic transnational collaboration, pursuing alignment on central management issues, and establishment of a common prospective database for future tracheal resection surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号